The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease
Open accessAbstract
The responses of central nervous system (CNS) cells such as neurons and glia in neurodegenerative diseases (NDs) suggest that regulation of neuronal and glial functions could be a strategy for ND prevention and/or treatment. However, attempts to develop such therapeutics for NDs have been hindered by the challenge of blood-brain barrier (BBB) permeability and continued constitutive neuronal loss. These limitations indicate the need for additional perspectives for the prevention/treatment of NDs. In particular, the disruption of the blood-brain barrier (BBB) that accompanies NDs allows brain infiltration by peripheral factors, which may stimulate innate immune responses involved in the progression of neurodegeneration. The accumulation of blood factors like thrombin, fibrinogen, c-reactive protein (CRP) and complement components in the brain has been observed in NDs and may activate the innate immune system in the CNS. Thus, strengthening the integrity of the BBB may enhance its protective role to attenuate ND progression and functional loss. In this review, we describe the innate immune system in the CNS and the contribution of blood factors to the role of the CNS immune system in neurodegeneration and neuroprotection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CRP usually does not freely cross BBB [33]”
From C-Reactive protein as a biomarker for major depressive disorder? (2022) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–210 of 210
Targeting CNS Transporters for Treatment of Neurodegenerative Diseases
Jedlitschky, G., Grube, M., Mosyagin, I., Kroemer, H. K., & Vogelgesang, S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990460 · Cited by 20
Schnoor, M., Alcaide, P., Voisin, M.-B., & van Buul, J. D. (2016) · Mediators of Inflammation · doi:10.1155/2016/1561368 · Cited by 20
Soluble Fibrinogen Triggers Non-cell Autonomous ER Stress-Mediated Microglial-Induced Neurotoxicity
Piers, T. M., East, E., Villegas-Llerena, C., Sevastou, I. G., Matarín, M., Hardy, J., & Pocock, J. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00404 · Cited by 20
Adams, M. J., Ward, C., Thom, J., Bianchi, A., Perrin, E. J., Coghlan, D. W., & Smith, M. (2007) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-971808 · Cited by 17
Arbustini, E., Narula, N., & D’Armini, A. M. (2013) · Circulation · doi:10.1161/circulationaha.113.005125 · Cited by 16
Nam, J. H., Leem, E., Jeon, M., Kim, Y., Jung, U. J., Choi, M.-S., Maeng, S., Jin, B. K., & Kim, S. R. (2014) · Neuroreport · doi:10.1097/wnr.0000000000000122 · Cited by 14
C-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells
Guo, H., Wang, H., Wang, C., Cheng, Y., Zou, Z., Li, Y., Wu, J., & Xu, J. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0572-z · Cited by 11
Drug discovery, development and delivery in Alzheimer’s disease
Brambilla, D. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2329-6 · Cited by 11
Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
das Neves, S. P., Serre-Miranda, C., Nóbrega, C., Roque, S., Cerqueira, J., Correia‐Neves, M., & Marques, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02335 · Cited by 10
SLEVIN, M. A., Liu, D., Ferris, G. R., Al-hsinawi, M., Al-Baradie, R. S., & Krupiński, J. (2016) · Turkish Journal of Pathology · doi:10.5146/tjpath.2016.01374 · Cited by 8
Flagged first, then by citations
Cited by
Sorted by citations
Inflammatory mediators in major depression and bipolar disorder
Poletti, S., Mazza, M. G., & Benedetti, F. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02921-z · Cited by 195
C-Reactive protein as a biomarker for major depressive disorder?
Orsolini, L., Pompili, S., Tempia Valenta, S., Salvi, V., & Volpe, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031616 · Cited by 171
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Zang, X., Chen, S., Zhu, J., Ma, J., & Zhai, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.872134 · Cited by 139
Potential Biomarkers for Post-Stroke Cognitive Impairment: A Systematic Review and Meta-Analysis
Kim, K. Y., Shin, K. Y., & Chang, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020602 · Cited by 139
Neuroinflammation and peripheral immunity: Focus on ischemic stroke
Wang, H., Zhang, S., Xie, L., Zhe, Z., & Yan, F. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110332 · Cited by 123
Metadata
- Authors
- Jeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G.
- Affiliations
- Korea Brain Research Institute (KR)
- Daegu Gyeongbuk Institute of Science and Technology (KR)
- King's College London (GB)
- Corresponding author
- Hoe, Hyang-Sook
- Kim, Do-Geun
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 68
- Pages
- 101333
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W3138731251
- Cited by
- 76
- References
- 210
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 15 · 2023: 14 · 2022: 16 · 2021: 4
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Ageing Research Reviews (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Research Foundation of Korea
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- blood-brain barrier disruption, neurodegenerative diseases, innate immunity, thrombin, fibrinogen, C-reactive protein, complement system, neuroinflammation, neuroprotection, glial cells, blood-brain barrier integrity
- MeSH terms
- Blood-Brain Barrier, Brain, Central Nervous System, Humans, Neuroglia, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
